# Karyopharm to Present Selinexor Data in Patients with Myelofibrosis and Multiple Myeloma at the 68th American Society of Hematology Annual Meeting and Exposition (ASH)

- Source: PR Newswire M&A
- Published: 2026-11-04T14:01:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/karyopharm-to-present-selinexor-data-in-patients-with-myelofibrosis-and-multiple-myeloma-at-the-68th-american-society-of-hematology-annual-meeting-and-exposition-ash-302928745.html
- Canonical: https://groundlevelnews.com/story/karyopharm-to-present-selinexor-data-in-patients-with-myelofibrosis-an-1582d7/

– Week 48 Data from the Phase 3 SENTRY Trial Selected for Oral Presentation – – Data from the Phase 2 SENTRY-2 Trial Selected for Oral Presentation – NEWTON, Mass., Nov. 4, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI) ("Karyopharm" or the "Company"), a commercial-stage...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._